- Home
- HSCS vs PLRZ Comparison
HSCS vs PLRZ Comparison
Compare HSCS & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- PLRZ
- Stock Information
- Founded
- HSCS 2007
- PLRZ 2005
- Country
- HSCS United States
- PLRZ Israel
- Employees
- HSCS N/A
- PLRZ N/A
- Industry
- HSCS Medical Specialities
- PLRZ
- Sector
- HSCS Health Care
- PLRZ
- Exchange
- HSCS Nasdaq
- PLRZ NYSE
- Market Cap
- HSCS 3.7M
- PLRZ 3.7M
- IPO Year
- HSCS 2022
- PLRZ 2024
- Fundamental
- Price
- HSCS $3.57
- PLRZ $0.69
- Analyst Decision
- HSCS Strong Buy
- PLRZ
- Analyst Count
- HSCS 2
- PLRZ 0
- Target Price
- HSCS $13.00
- PLRZ N/A
- AVG Volume (30 Days)
- HSCS 50.6K
- PLRZ 3.0M
- Earning Date
- HSCS 07-28-2025
- PLRZ 02-15-2025
- Dividend Yield
- HSCS N/A
- PLRZ N/A
- EPS Growth
- HSCS N/A
- PLRZ N/A
- EPS
- HSCS N/A
- PLRZ N/A
- Revenue
- HSCS N/A
- PLRZ N/A
- Revenue This Year
- HSCS N/A
- PLRZ N/A
- Revenue Next Year
- HSCS N/A
- PLRZ N/A
- P/E Ratio
- HSCS N/A
- PLRZ N/A
- Revenue Growth
- HSCS 261.17
- PLRZ N/A
- 52 Week Low
- HSCS $2.36
- PLRZ $0.55
- 52 Week High
- HSCS $5.30
- PLRZ $1,200.00
- Technical
- Relative Strength Index (RSI)
- HSCS 46.34
- PLRZ N/A
- Support Level
- HSCS $3.63
- PLRZ N/A
- Resistance Level
- HSCS $3.92
- PLRZ N/A
- Average True Range (ATR)
- HSCS 0.31
- PLRZ 0.00
- MACD
- HSCS -0.02
- PLRZ 0.00
- Stochastic Oscillator
- HSCS 8.75
- PLRZ 0.00
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.